ELDRED KARY 4
4 · GALECTIN THERAPEUTICS INC · Filed Jan 25, 2022
Insider Transaction Report
Form 4
ELDRED KARY
Director
Transactions
- Award
Stock Option (right to buy)
2022-01-24+40,000→ 40,000 totalExercise: $1.98Exp: 2032-01-24→ Common Stock (40,000 underlying)
Footnotes (2)
- [F1]The options were issued pursuant to the Galectin Therapeutics Inc. 2019 Omnibus Equity Incentive Plan.
- [F2]The options vest 100% on December 31, 2022.